Oura and Investors Target Up to $3B US IPO at $16B-Plus Valuation

Smart ring developer Oura and several of its key financial supporters are exploring an initial public offering in the United States that could raise as much as $3 billion, according to individuals familiar with the planning first reported by Bloomberg. The upcoming stock market debut could assess the health technology entity at a valuation exceeding $16 billion, marking a major liquidity event for the wearable hardware maker and its investor base.

The proposed capital raise is structured to include both primary shares issued directly by Oura to generate fresh balance-sheet capital and secondary shares offered by existing backers seeking to realize returns on their early investment holdings. While final details surrounding the exact equity distribution remain subject to institutional demand, the prospective transaction would rank among the largest technology public debuts in recent U.S. market history.

Target timing for the initial public offering indicates that the listing could occur as early as September, provided regulatory filings proceed without delay and broader macroeconomic conditions remain receptive to high-growth tech debuts. Sources indicated that while discussions are actively moving forward, the precise window for the public presentation and registration remains dependent on ongoing financial reviews and market feedback.

A successful listing at the targeted parameters would establish Oura as one of the premier standalone publicly traded firms in the specialized wearable health monitoring category. The expected valuation of more than $16 billion underscores a notable increase from previous private financing rounds, reflecting heightened investor interest in personal wellness tracking devices and consumer health data platforms.

The involvement of early venture backers alongside company management in the planned $3 billion transaction highlights a dual objective: raising substantial capital to support further business expansion and providing liquidity for long-standing equity holders. Broad participation among existing investors typically signals confidence in public market appetite while allowing funds to distribute capital back to their underlying limited partners.

Selecting a U.S. stock exchange for the proposed debut allows Oura to tap into a deep pool of institutional liquidity, where public markets have increasingly evaluated specialized consumer hardware and subscription-based health monitoring enterprises. The move aligns with broader patterns of mature technology scale-ups seeking public listings in New York to widen their shareholder base and establish a liquid public equity currency.

As preparations for the target September launch continue, further details regarding designated lead underwriting banks, specific primary-versus-secondary share allocation ratios, and preliminary prospectus filings are expected to emerge. However, persons close to the matter emphasized that the overall size, timing, and final valuation target for the offering could still be adjusted based on market dynamics prior to the official filing.